Nuclear factor‐κB activation predicts an unfavourable outcome in human upper urinary tract urothelial carcinoma

OBJECTIVE To examine the hypothesis that nuclear factor‐κB (NF‐κB), a transcription factor involved in anti‐apoptosis, invasion, and angiogenesis, plays a role in the carcinogenesis of upper urinary tract urothelial carcinoma (UUT‐UC) and has prognostic value for survival. PATIENTS AND METHODS In al...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BJU international 2010-10, Vol.106 (8), p.1223-1229
Hauptverfasser: Yeh, Hsin‐Chih, Huang, Chun‐Hsiung, Yang, Sheau‐Fang, Li, Ching‐Chia, Chang, Lin‐Li, Lin, Hui‐Hui, Ke, Hung‐Lung, Wei, Yu‐Ching, Wu, Wen‐Jeng
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1229
container_issue 8
container_start_page 1223
container_title BJU international
container_volume 106
creator Yeh, Hsin‐Chih
Huang, Chun‐Hsiung
Yang, Sheau‐Fang
Li, Ching‐Chia
Chang, Lin‐Li
Lin, Hui‐Hui
Ke, Hung‐Lung
Wei, Yu‐Ching
Wu, Wen‐Jeng
description OBJECTIVE To examine the hypothesis that nuclear factor‐κB (NF‐κB), a transcription factor involved in anti‐apoptosis, invasion, and angiogenesis, plays a role in the carcinogenesis of upper urinary tract urothelial carcinoma (UUT‐UC) and has prognostic value for survival. PATIENTS AND METHODS In all, 90 patients with UUT‐UC [mean (range) age, 64.5 (24–84) years] who underwent surgery at our institution from January 1991 to December 2005 were included. Clinicopathological data were collected retrospectively. We performed immunohistochemical staining for NF‐κB (p65) on paraffin‐embedded sections of the tumour and corresponding normal tissues. The association between survival and potential prognostic factors was examined. RESULTS The median follow‐up was 40 months. In all, 55 patients (61.1%) with UUT‐UC overexpressed cytoplasmic NF‐κB, and nuclear immunoreactivity for NF‐κB was detected in 24 patients (26.7%). On univariate analysis, significant prognostic factors for survival were tumour location, stage, grade, lymph node involvement, and nuclear NF‐κB expression. On multivariate analysis, nuclear NF‐κB positivity was an independent predictor for disease‐specific survival [Cox regression hazard ratio (HR) 2.87; P= 0.025] and overall survival (HR 2.24; P= 0.037). CONCLUSION These results imply a role for nuclear NF‐κB expression in the tumorigenesis of UUT‐UC. Nuclear NF‐κB may serve as a useful independent molecular marker to predict outcome and may represent a promising therapeutic target for patients with UUT‐UC.
doi_str_mv 10.1111/j.1464-410X.2010.09210.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_816530164</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>816530164</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3980-987df0aea5d54d188c066029e591713e9ad9f6adb6681f919877861895db5e333</originalsourceid><addsrcrecordid>eNqNkE9u1TAQxi1ERUvhCsgbxOq92nHi2AsWtOJPUVU2VGJnzXMmqp-cONhxaXccgfNwCA7BSXB4r2WLF_bnmd_M2B8hlLM1L-tku-a1rFc1Z1_WFStRpquy3z4iRw-Jx_eaaXlInqa0ZawEZPOEHJYaUXEtj0i8zNYjRNqDnUP8_f3Hr5-ntGh3A7MLI50ids7OicJI89jDTcgRNh5pyLMNA1I30us8LNlpwkhzdCPEOzrH0qTcwnyN3oGnFqJ1YxjgGTnowSd8vj-PydW7t5_PPqwuPr0_P3tzsbJCK7bSqu16BghN19QdV8oyKVmlsdG85QI1dLqX0G2kVLzXvPCtklzppts0KIQ4Jq92facYvmZMsxlcsug9jBhyMorLRjAu60KqHWljSClib6bohvILw5lZDDdbs3hpFl_NYrj5a7i5LaUv9kPyZsDuofDe4QK83AOQLPg-wmhd-seJSrWSt4V7veO-OY93__0Ac_rxalHiD9ClnzY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>816530164</pqid></control><display><type>article</type><title>Nuclear factor‐κB activation predicts an unfavourable outcome in human upper urinary tract urothelial carcinoma</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Yeh, Hsin‐Chih ; Huang, Chun‐Hsiung ; Yang, Sheau‐Fang ; Li, Ching‐Chia ; Chang, Lin‐Li ; Lin, Hui‐Hui ; Ke, Hung‐Lung ; Wei, Yu‐Ching ; Wu, Wen‐Jeng</creator><creatorcontrib>Yeh, Hsin‐Chih ; Huang, Chun‐Hsiung ; Yang, Sheau‐Fang ; Li, Ching‐Chia ; Chang, Lin‐Li ; Lin, Hui‐Hui ; Ke, Hung‐Lung ; Wei, Yu‐Ching ; Wu, Wen‐Jeng</creatorcontrib><description>OBJECTIVE To examine the hypothesis that nuclear factor‐κB (NF‐κB), a transcription factor involved in anti‐apoptosis, invasion, and angiogenesis, plays a role in the carcinogenesis of upper urinary tract urothelial carcinoma (UUT‐UC) and has prognostic value for survival. PATIENTS AND METHODS In all, 90 patients with UUT‐UC [mean (range) age, 64.5 (24–84) years] who underwent surgery at our institution from January 1991 to December 2005 were included. Clinicopathological data were collected retrospectively. We performed immunohistochemical staining for NF‐κB (p65) on paraffin‐embedded sections of the tumour and corresponding normal tissues. The association between survival and potential prognostic factors was examined. RESULTS The median follow‐up was 40 months. In all, 55 patients (61.1%) with UUT‐UC overexpressed cytoplasmic NF‐κB, and nuclear immunoreactivity for NF‐κB was detected in 24 patients (26.7%). On univariate analysis, significant prognostic factors for survival were tumour location, stage, grade, lymph node involvement, and nuclear NF‐κB expression. On multivariate analysis, nuclear NF‐κB positivity was an independent predictor for disease‐specific survival [Cox regression hazard ratio (HR) 2.87; P= 0.025] and overall survival (HR 2.24; P= 0.037). CONCLUSION These results imply a role for nuclear NF‐κB expression in the tumorigenesis of UUT‐UC. Nuclear NF‐κB may serve as a useful independent molecular marker to predict outcome and may represent a promising therapeutic target for patients with UUT‐UC.</description><identifier>ISSN: 1464-4096</identifier><identifier>EISSN: 1464-410X</identifier><identifier>DOI: 10.1111/j.1464-410X.2010.09210.x</identifier><identifier>PMID: 20132196</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Biological and medical sciences ; Biomarkers, Tumor - metabolism ; Female ; Humans ; immunohistochemistry ; Kidney Neoplasms - metabolism ; Kidney Neoplasms - pathology ; Kidney Neoplasms - surgery ; Kidney Pelvis ; Male ; Medical sciences ; Middle Aged ; Multivariate Analysis ; Nephrology. Urinary tract diseases ; NF-kappa B - metabolism ; NF‐κB ; p65 ; Prognosis ; Retrospective Studies ; Survival Analysis ; Tumors of the urinary system ; upper urinary tract ; Ureteral Neoplasms - metabolism ; Ureteral Neoplasms - pathology ; Ureteral Neoplasms - surgery ; Urinary system involvement in other diseases. Miscellaneous ; Urinary tract. Prostate gland ; urothelial carcinoma ; Young Adult</subject><ispartof>BJU international, 2010-10, Vol.106 (8), p.1223-1229</ispartof><rights>2010 THE AUTHORS. JOURNAL COMPILATION © 2010 BJU INTERNATIONAL</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3980-987df0aea5d54d188c066029e591713e9ad9f6adb6681f919877861895db5e333</citedby><cites>FETCH-LOGICAL-c3980-987df0aea5d54d188c066029e591713e9ad9f6adb6681f919877861895db5e333</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1464-410X.2010.09210.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1464-410X.2010.09210.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27923,27924,45573,45574</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=23287617$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20132196$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yeh, Hsin‐Chih</creatorcontrib><creatorcontrib>Huang, Chun‐Hsiung</creatorcontrib><creatorcontrib>Yang, Sheau‐Fang</creatorcontrib><creatorcontrib>Li, Ching‐Chia</creatorcontrib><creatorcontrib>Chang, Lin‐Li</creatorcontrib><creatorcontrib>Lin, Hui‐Hui</creatorcontrib><creatorcontrib>Ke, Hung‐Lung</creatorcontrib><creatorcontrib>Wei, Yu‐Ching</creatorcontrib><creatorcontrib>Wu, Wen‐Jeng</creatorcontrib><title>Nuclear factor‐κB activation predicts an unfavourable outcome in human upper urinary tract urothelial carcinoma</title><title>BJU international</title><addtitle>BJU Int</addtitle><description>OBJECTIVE To examine the hypothesis that nuclear factor‐κB (NF‐κB), a transcription factor involved in anti‐apoptosis, invasion, and angiogenesis, plays a role in the carcinogenesis of upper urinary tract urothelial carcinoma (UUT‐UC) and has prognostic value for survival. PATIENTS AND METHODS In all, 90 patients with UUT‐UC [mean (range) age, 64.5 (24–84) years] who underwent surgery at our institution from January 1991 to December 2005 were included. Clinicopathological data were collected retrospectively. We performed immunohistochemical staining for NF‐κB (p65) on paraffin‐embedded sections of the tumour and corresponding normal tissues. The association between survival and potential prognostic factors was examined. RESULTS The median follow‐up was 40 months. In all, 55 patients (61.1%) with UUT‐UC overexpressed cytoplasmic NF‐κB, and nuclear immunoreactivity for NF‐κB was detected in 24 patients (26.7%). On univariate analysis, significant prognostic factors for survival were tumour location, stage, grade, lymph node involvement, and nuclear NF‐κB expression. On multivariate analysis, nuclear NF‐κB positivity was an independent predictor for disease‐specific survival [Cox regression hazard ratio (HR) 2.87; P= 0.025] and overall survival (HR 2.24; P= 0.037). CONCLUSION These results imply a role for nuclear NF‐κB expression in the tumorigenesis of UUT‐UC. Nuclear NF‐κB may serve as a useful independent molecular marker to predict outcome and may represent a promising therapeutic target for patients with UUT‐UC.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Biomarkers, Tumor - metabolism</subject><subject>Female</subject><subject>Humans</subject><subject>immunohistochemistry</subject><subject>Kidney Neoplasms - metabolism</subject><subject>Kidney Neoplasms - pathology</subject><subject>Kidney Neoplasms - surgery</subject><subject>Kidney Pelvis</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Multivariate Analysis</subject><subject>Nephrology. Urinary tract diseases</subject><subject>NF-kappa B - metabolism</subject><subject>NF‐κB</subject><subject>p65</subject><subject>Prognosis</subject><subject>Retrospective Studies</subject><subject>Survival Analysis</subject><subject>Tumors of the urinary system</subject><subject>upper urinary tract</subject><subject>Ureteral Neoplasms - metabolism</subject><subject>Ureteral Neoplasms - pathology</subject><subject>Ureteral Neoplasms - surgery</subject><subject>Urinary system involvement in other diseases. Miscellaneous</subject><subject>Urinary tract. Prostate gland</subject><subject>urothelial carcinoma</subject><subject>Young Adult</subject><issn>1464-4096</issn><issn>1464-410X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkE9u1TAQxi1ERUvhCsgbxOq92nHi2AsWtOJPUVU2VGJnzXMmqp-cONhxaXccgfNwCA7BSXB4r2WLF_bnmd_M2B8hlLM1L-tku-a1rFc1Z1_WFStRpquy3z4iRw-Jx_eaaXlInqa0ZawEZPOEHJYaUXEtj0i8zNYjRNqDnUP8_f3Hr5-ntGh3A7MLI50ids7OicJI89jDTcgRNh5pyLMNA1I30us8LNlpwkhzdCPEOzrH0qTcwnyN3oGnFqJ1YxjgGTnowSd8vj-PydW7t5_PPqwuPr0_P3tzsbJCK7bSqu16BghN19QdV8oyKVmlsdG85QI1dLqX0G2kVLzXvPCtklzppts0KIQ4Jq92facYvmZMsxlcsug9jBhyMorLRjAu60KqHWljSClib6bohvILw5lZDDdbs3hpFl_NYrj5a7i5LaUv9kPyZsDuofDe4QK83AOQLPg-wmhd-seJSrWSt4V7veO-OY93__0Ac_rxalHiD9ClnzY</recordid><startdate>201010</startdate><enddate>201010</enddate><creator>Yeh, Hsin‐Chih</creator><creator>Huang, Chun‐Hsiung</creator><creator>Yang, Sheau‐Fang</creator><creator>Li, Ching‐Chia</creator><creator>Chang, Lin‐Li</creator><creator>Lin, Hui‐Hui</creator><creator>Ke, Hung‐Lung</creator><creator>Wei, Yu‐Ching</creator><creator>Wu, Wen‐Jeng</creator><general>Blackwell Publishing Ltd</general><general>Wiley-Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201010</creationdate><title>Nuclear factor‐κB activation predicts an unfavourable outcome in human upper urinary tract urothelial carcinoma</title><author>Yeh, Hsin‐Chih ; Huang, Chun‐Hsiung ; Yang, Sheau‐Fang ; Li, Ching‐Chia ; Chang, Lin‐Li ; Lin, Hui‐Hui ; Ke, Hung‐Lung ; Wei, Yu‐Ching ; Wu, Wen‐Jeng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3980-987df0aea5d54d188c066029e591713e9ad9f6adb6681f919877861895db5e333</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Biomarkers, Tumor - metabolism</topic><topic>Female</topic><topic>Humans</topic><topic>immunohistochemistry</topic><topic>Kidney Neoplasms - metabolism</topic><topic>Kidney Neoplasms - pathology</topic><topic>Kidney Neoplasms - surgery</topic><topic>Kidney Pelvis</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Multivariate Analysis</topic><topic>Nephrology. Urinary tract diseases</topic><topic>NF-kappa B - metabolism</topic><topic>NF‐κB</topic><topic>p65</topic><topic>Prognosis</topic><topic>Retrospective Studies</topic><topic>Survival Analysis</topic><topic>Tumors of the urinary system</topic><topic>upper urinary tract</topic><topic>Ureteral Neoplasms - metabolism</topic><topic>Ureteral Neoplasms - pathology</topic><topic>Ureteral Neoplasms - surgery</topic><topic>Urinary system involvement in other diseases. Miscellaneous</topic><topic>Urinary tract. Prostate gland</topic><topic>urothelial carcinoma</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yeh, Hsin‐Chih</creatorcontrib><creatorcontrib>Huang, Chun‐Hsiung</creatorcontrib><creatorcontrib>Yang, Sheau‐Fang</creatorcontrib><creatorcontrib>Li, Ching‐Chia</creatorcontrib><creatorcontrib>Chang, Lin‐Li</creatorcontrib><creatorcontrib>Lin, Hui‐Hui</creatorcontrib><creatorcontrib>Ke, Hung‐Lung</creatorcontrib><creatorcontrib>Wei, Yu‐Ching</creatorcontrib><creatorcontrib>Wu, Wen‐Jeng</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>BJU international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yeh, Hsin‐Chih</au><au>Huang, Chun‐Hsiung</au><au>Yang, Sheau‐Fang</au><au>Li, Ching‐Chia</au><au>Chang, Lin‐Li</au><au>Lin, Hui‐Hui</au><au>Ke, Hung‐Lung</au><au>Wei, Yu‐Ching</au><au>Wu, Wen‐Jeng</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nuclear factor‐κB activation predicts an unfavourable outcome in human upper urinary tract urothelial carcinoma</atitle><jtitle>BJU international</jtitle><addtitle>BJU Int</addtitle><date>2010-10</date><risdate>2010</risdate><volume>106</volume><issue>8</issue><spage>1223</spage><epage>1229</epage><pages>1223-1229</pages><issn>1464-4096</issn><eissn>1464-410X</eissn><abstract>OBJECTIVE To examine the hypothesis that nuclear factor‐κB (NF‐κB), a transcription factor involved in anti‐apoptosis, invasion, and angiogenesis, plays a role in the carcinogenesis of upper urinary tract urothelial carcinoma (UUT‐UC) and has prognostic value for survival. PATIENTS AND METHODS In all, 90 patients with UUT‐UC [mean (range) age, 64.5 (24–84) years] who underwent surgery at our institution from January 1991 to December 2005 were included. Clinicopathological data were collected retrospectively. We performed immunohistochemical staining for NF‐κB (p65) on paraffin‐embedded sections of the tumour and corresponding normal tissues. The association between survival and potential prognostic factors was examined. RESULTS The median follow‐up was 40 months. In all, 55 patients (61.1%) with UUT‐UC overexpressed cytoplasmic NF‐κB, and nuclear immunoreactivity for NF‐κB was detected in 24 patients (26.7%). On univariate analysis, significant prognostic factors for survival were tumour location, stage, grade, lymph node involvement, and nuclear NF‐κB expression. On multivariate analysis, nuclear NF‐κB positivity was an independent predictor for disease‐specific survival [Cox regression hazard ratio (HR) 2.87; P= 0.025] and overall survival (HR 2.24; P= 0.037). CONCLUSION These results imply a role for nuclear NF‐κB expression in the tumorigenesis of UUT‐UC. Nuclear NF‐κB may serve as a useful independent molecular marker to predict outcome and may represent a promising therapeutic target for patients with UUT‐UC.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>20132196</pmid><doi>10.1111/j.1464-410X.2010.09210.x</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1464-4096
ispartof BJU international, 2010-10, Vol.106 (8), p.1223-1229
issn 1464-4096
1464-410X
language eng
recordid cdi_proquest_miscellaneous_816530164
source MEDLINE; Wiley Online Library All Journals
subjects Adult
Aged
Aged, 80 and over
Biological and medical sciences
Biomarkers, Tumor - metabolism
Female
Humans
immunohistochemistry
Kidney Neoplasms - metabolism
Kidney Neoplasms - pathology
Kidney Neoplasms - surgery
Kidney Pelvis
Male
Medical sciences
Middle Aged
Multivariate Analysis
Nephrology. Urinary tract diseases
NF-kappa B - metabolism
NF‐κB
p65
Prognosis
Retrospective Studies
Survival Analysis
Tumors of the urinary system
upper urinary tract
Ureteral Neoplasms - metabolism
Ureteral Neoplasms - pathology
Ureteral Neoplasms - surgery
Urinary system involvement in other diseases. Miscellaneous
Urinary tract. Prostate gland
urothelial carcinoma
Young Adult
title Nuclear factor‐κB activation predicts an unfavourable outcome in human upper urinary tract urothelial carcinoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T10%3A01%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nuclear%20factor%E2%80%90%CE%BAB%20activation%20predicts%20an%20unfavourable%20outcome%20in%20human%20upper%20urinary%20tract%20urothelial%20carcinoma&rft.jtitle=BJU%20international&rft.au=Yeh,%20Hsin%E2%80%90Chih&rft.date=2010-10&rft.volume=106&rft.issue=8&rft.spage=1223&rft.epage=1229&rft.pages=1223-1229&rft.issn=1464-4096&rft.eissn=1464-410X&rft_id=info:doi/10.1111/j.1464-410X.2010.09210.x&rft_dat=%3Cproquest_cross%3E816530164%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=816530164&rft_id=info:pmid/20132196&rfr_iscdi=true